3400 Organometallics, Vol. 22, No. 17, 2003
Hooper and Hartwig
sodium/ benzophenone prior to use. 3-Bromofuran was distilled
prior to use. 2-Bromofuran,44 2-bromo-5-methylfuran, 44 2-bromo-
5-methylthiophene,44 and 3-bromo-N-methylindole45 were all
prepared according to literature procedures. All other chemi-
cals were used as received from commercial suppliers.
Gen er a l P r oced u r e for th e P r ep a r a tion of (DP P F )P d -
(Heter oa r yl)Br Com p lexes, 1a -f. In a drybox, Pd(P(o-
tolyl)3)2 (0.71 mmol) was weighed directly into a screw-capped
vial. A stir bar was added, followed by 10 mL of benzene. The
heteroaryl bromide (2.84 mmol, 4 equiv) was added and stirred
for 10 min. DPPF (391 mg, 0.71 mmol) was dissolved in 10
mL of benzene and added dropwise over 2 min. The reaction
was monitored by removing an aliquot, adding 0.5 mL of CH2-
Cl2 to ensure homogeneity, and obtaining a 31P NMR spectrum.
Upon completion of the reaction, the yellow precipitate was
filtered, washed with 5 mL of benzene, then 2 × 5 mL of
pentane, and dried in vacuo.
(DP P F )P d (2-C4H3O)(Br ), 1a . The above general procedure
was followed using Pd(P(o-tolyl)3)2 (500 mg, 0.71 mmol),
2-bromofuran (418 mg, 251 µL, 2.8 mmol), and DPPF (391 mg,
0.71 mmol) in 20 mL of benzene to give 476 mg (83%) of
(DPPF)Pd(2-C4H3O)(Br) as a yellow solid: 1H NMR (400 MHz,
CD2Cl2) δ 7.99 (m, 4H), 7.51 (m, 10H), 7.40 (m, 2H), 7.26 (m,
4H), 7.10 (bs, 1H), 5.94 (bs, 1H), 5.65 (bs, 1H), 4.61 (bs, 2H),
4.46 (bs, 2H), 4.21 (m, 2H), 3.83 (bs, 2H); 13C{1H} NMR (101
MHz, CD2Cl2) δ 154.73 (dd, J CP ) 164.3, 9.8 Hz), 146.56 (d,
J CP ) 5.6 Hz), 136.14 (d, J CP ) 11.9 Hz), 134.76 (d, J CP ) 12.2
Hz), 133.62(d, J CP ) 51.7 Hz), 133.53 (d, J CP ) 45.8 Hz), 131.24,
131.23, 128.85 (d, J CP ) 9.9 Hz), 128.79 (d, J CP ) 11.1 Hz),
115.13 (dd, J CP ) 5.5 Hz, 13.4 Hz), 111.78 (d, J CP ) 6.1 Hz),
77.40 (dd, J CP ) 58.3, 7.9 Hz), 76.77 (d, J CP ) 11.1 Hz), 75.32
(d, J CP ) 8.7 Hz), 75.05 (dd, J CP ) 45.0, 3.3 Hz), 74.32 (d,
J CP ) 7.3 Hz), 73.49 (d, J CP ) 5.3 Hz); 31P{1H} NMR (202 MHz,
CD2Cl2) δ 28.36 (d, J PP ) 21.3 Hz), 13.17 (d, J PP ) 21.7 Hz).
Anal. Calcd for C38H31BrFeOP2Pd: C, 56.58; H, 3.88. Found:
C, 56.82; H, 3.60.
(m), 128.60 (d, J CP ) 10.0 Hz), 128.44 (d, J CP ) 11.1 Hz), 127.04
(d, J CP ) 11.3 Hz), 77.22 (dd, J CP ) 51.3, 8.3 Hz), 76.70 (d,
J CP ) 11.3 Hz), 74.92 (d, J CP ) 8.5 Hz), 74.85 (dd, J CP ) 33.0,
2.3 Hz), 74.21 (d, J CP ) 7.5 Hz), 73.18 (d, J CP ) 5.3 Hz); 31P{1H}
(202 MHz, CD2Cl2) NMR δ 30.77 (d, J PP ) 21.0 Hz), 12.68 (d,
J PP ) 20.8 Hz). Anal. Calcd for C38H31BrFeSP2Pd: C, 55.48;
H, 3.77; S, 3.89. Found: C, 55.50; H, 3.98; S, 3.62.
(DP P F )P d (3-C4H3S)(Br ), 1d . The above general procedure
was followed using Pd(P(o-tolyl)3)2 (500 mg, 0.71 mmol),
3-bromothiophene (457 mg, 262 µL, 2.8 mmol), and DPPF (391
mg, 0.71 mmol) in 20 mL of benzene to give 374 mg (64%) of
(DPPF)Pd(3-C4H3S)(Br) as a yellow solid: 1H NMR (400 MHz,
CD2Cl2) δ 8.02 (m, 4H), 7.51 (m, 6H), 7.44 (dd, J HH ) 7.9 Hz,
J HP ) 12.1 Hz, 4H), 7.36 (m, 2H), 7.20 (t of d, J HH ) 7.8 Hz,
J HP ) 2.2 Hz, 4H), 6.76 (quin, J ) 2.3 Hz, 1H), 6.48 (m, 1H),
6.24 (m, 1H), 4.63 (m, 2H), 4.47 (m, 2H), 4.18 (m, 2H), 3.77 (q,
J ) 1.8 Hz, 2H); 13C{1H} NMR (101 MHz, CD2Cl2) 144.88 (dd,
J CP ) 130.8, 7.2 Hz), 135.91 (d, J CP ) 12.0 Hz), 134.41 (d,
J CP ) 11.9 Hz), 133.72 (d, J CP ) 37.0 Hz), 133.49 (d, J CP
)
56.4 Hz), 133.31 (m), 130.85, 130.84, 128.57 (d, J CP ) 9.8 Hz),
128.51 (d, J CP ) 11.1 Hz), 122.20 (d, J CP ) 11.8 Hz), 119.35
(m), 77.48 (dd, J CP ) 51.3, 7.9 Hz), 76.46 (d, J CP ) 11.3 Hz),
75.15 (dd, J CP ) 39.5, 3.0 Hz), 74.84 (d, J CP ) 8.6 Hz), 74.01
(d, J CP ) 7.4 Hz), 73.04 (d, J CP ) 5.0 Hz); 31P{1H} NMR (162
MHz, CD2Cl2) δ 30.07 (d, J PP ) 26.0 Hz), 11.33 (d, J PP ) 25.9
Hz).
(DP P F )P d (2-(5-CH3)C4H3S)(Br ), 1e. The above general
procedure was followed using Pd(P(o-tolyl)3)2 (500 mg, 0.71
mmol), 2-bromo-5-methylthiophene (496 mg, 315 µL, 2.8
mmol), and DPPF (391 mg, 0.71 mmol) in 20 mL of benzene
to give 297 mg (50%) of (DPPF)Pd(2-(5-CH3)C4H3S)(Br) as a
yellow solid: 1H NMR (400 MHz, CD2Cl2) δ 8.00 (m, 4H), 7.53-
7.46 (m, 10H), 7.39 (m, 2H), 7.21 (t of d, J HH ) 8.0 Hz, J HP
)
2.4 Hz, 4H), 6.19 (bs, 1H), 5.89 (m, 1H), 4.64 (m, 2H), 4.47
(bs, 2H), 4.18 (m, 2H), 3.75 (m, 2H), 2.18 (s, 3H); 13C{1H} NMR
(126 MHz, CD2Cl2) δ 144.23 (m), 142.70 (dd, J CP ) 150.9, 10.6
Hz) 135.96 (d, J CP ) 11.7 Hz), 134.65 (d, J CP ) 12.0 Hz), 133.53
(d, J CP ) 38.8 Hz), 132.14 (d, J CP ) 57.1 Hz), 130.94 (m), 130.89
(m), 129.45 (m), 128.60 (d, J CP ) 9.7 Hz), 128.39 (d, J CP ) 10.9
Hz), 126.21 (d, J CP ) 10.2 Hz), 77.42 (dd, J CP ) 50.2, 8.0 Hz),
76.66 (d, J CP ) 11.1 Hz), 74.95 (dd, J CP ) 43.2, 3.8 Hz), 74.92
(d, J CP ) 8.5 Hz), 74.13 (d, J CP ) 7.4 Hz), 73.14 (d, J CP ) 5.1
(DP P F )P d (3-C4H3O)(Br ), 1b. The above general procedure
was followed using Pd(P(o-tolyl)3)2 (500 mg, 0.71 mmol),
3-bromofuran (418 mg, 256 µL, 2.8 mmol), and DPPF (391 mg,
0.71 mmol) in 20 mL of benzene to give 482 mg (84%) of
(DPPF)Pd(3-C4H3O)(Br) as a yellow solid: 1H NMR (400 MHz,
CD2Cl2) δ 7.99 (m, 4H), 7.51 (m, 10H), 7.40 (m, 2H), 7.26 (m,
4H), 6.90 (bs, 1H), 6.20 (m, 1H), 5.72 (m, 1H), 4.58 (q, J ) 1.9
Hz, 2H), 4.44 (m, 2H), 4.19 (m, 2H), 3.83 (q, J ) 1.8 Hz, 2H);
13C{1H} NMR (101 MHz, CD2Cl2) δ 140.64 (d, J CP ) 8.1 Hz),
139.66 (m), 136.18 (d, J CP ) 11.9 Hz), 134.86 (d, J CP ) 11.9
Hz), 134.04 (d, J CP ) 25.2 Hz), 134.56 (d, J CP ) 43.3 Hz), 131.29
Hz), 15.68; 31P{1H} NMR (162 MHz, CD2Cl2) δ 30.18 (d, J PP
22.2 Hz), 12.32 (d, J PP ) 22.2 Hz). Anal. Calcd for C39H33
BrFeSP2Pd: C, 55.99; H, 3.98. Found: C, 55.83; H, 4.05.
)
-
(DP P F )P d (2-(3-CH3)C4H3S)(Br ), 1f. The above general
procedure was followed using Pd(P(o-tolyl)3)2 (500 mg, 0.71
mmol), 2-bromo-3-methylthiophene (496 mg, 311 µL, 2.8
mmol), and DPPF (391 mg, 0.71 mmol) in 20 mL of benzene
to give 315 mg (53%) of (DPPF)Pd(2-(3-CH3)C4H3S)(Br) as a
yellow solid: 1H NMR (500 MHz, CD2Cl2) δ 8.06 (m, 2H), 7.98
(m, 2H), 7.81 (m, 2H), 7.56 (m, 2H), 7.49 (m, 4H), 7.31 (t of d,
J HH ) 7.8 Hz, J HP ) 2.4 Hz, 2H), 7.22 (m, 2H), 7.01 (m, 5H),
6.32 (dd, J HH ) 4.8 Hz, J HP ) 2.2 Hz, 1H), 4.88 (m, 1H), 4.58
(m, 1H), 4.47 (bs, 1H), 4.44 (m, 1H), 4.17 (m, 2H), 3.75 (m,
1H), 3.58 (m, 1H), 1.91 (s, 3H); 13C{1H} NMR (126 MHz, CD2-
Cl2) 140.97 (dd, J CP ) 146.8, 8.6 Hz), 137.25 (m), 136.63 (d,
(d, J CP ) 2.5 Hz), 131.15 (d, J CP ) 2.4 Hz), 128.83 (d, J CP
5.2 Hz), 128.73 (d, J CP ) 6.4 Hz), 124.21 (dd, J CP ) 138.2, 10.3
Hz), 116.83 (m), 77.83 (dd, J CP ) 49.9, 8.0 Hz), 76.65 (d, J CP
)
)
11.0 Hz), 75.26 (dd, J CP ) 40.6, 3.4 Hz), 75.20 (d, J CP ) 8.7
Hz), 74.26 (d, J CP ) 7.1 Hz), 73.46 (d, J CP ) 4.8 Hz); 31P{1H}
NMR (162 MHz, CD2Cl2) δ 30.18 (d, J CP ) 21.8 Hz), 11.98 (d,
J CP ) 21.7 Hz).
(DP P F )P d (2-C4H3S)(Br ), 1c. The above general procedure
was followed using Pd(P(o-tolyl)3)2 (500 mg, 0.71 mmol),
2-bromothiophene (457 mg, 273 µL, 2.8 mmol), and DPPF (391
mg, 0.71 mmol) in 20 mL of benzene to give 509 mg (87%) of
(DPPF)Pd(2-C4H3S)(Br) as a yellow solid: 1H NMR (500 MHz,
CD2Cl2) δ 8.02 (m, 4H), 7.52 (m, 6H), 7.46 (dd, J HH ) 7.2 Hz,
J HP ) 12.1 Hz, 4H), 7.37 (m, 2H), 7.20 (t of d, J HH ) 7.9 Hz,
J CP ) 12.3 Hz), 136.36 (d, J CP ) 13.3 Hz), 135.67 (d, J CP
)
10.9 Hz), 134.86 (d, J CP ) 62.6 Hz), 134.48 (d, J CP ) 41.6 Hz),
133.33 (d, J CP ) 104.8 Hz), 133.17 (d, J CP ) 10.8 Hz), 132.51
(d, J CP ) 55.2 Hz), 132.22 (m), 131.47 (m), 130.91 (m), 130.59
(d, J CP ) 11.2 Hz), 130.24 (m), 129.38 (m), 128.97 (d, J CP
)
J HP ) 2.4 Hz, 4H), 7.06 (m, 1H), 6.56 (m, 1H), 6.17 (dd, J HH
)
9.8 Hz), 128.94 (d, J CP ) 11.2 Hz), 128.72 (d, J CP ) 9.6 Hz),
127.89 (d, J CP ) 10.7 Hz), 78.00 (d, J CP ) 16.9 Hz), 77.36 (dd,
J HP ) 3.9 Hz, 1H), 4.66 (q, J ) 1.9 Hz, 2H), 4.49 (m, 2H), 4.19
(m, 2H), 3.74 (q, J ) 1.7 Hz, 2H); 13C{1H} NMR (101 MHz,
CD2Cl2) δ 146.79 (dd, J CP ) 150.3, 10.5 Hz), 135.92 (d, J CP
J CP ) 51.0, 7.4 Hz), 76.08 (d, J CP ) 6.3 Hz), 75.34 (dd, J CP
)
)
42.1, 3.6 Hz), 75.27, 75.22 (m), 75.21 (d, J CP ) 6.7 Hz), 74.21
(d, J CP ) 5.9 Hz), 73.74 (d, J CP ) 6.0 Hz), 72.39 (d, J CP ) 4.4
11.8 Hz), 134.50 (d, J CP ) 11.8 Hz), 133.39 (d, J CP ) 40.1 Hz),
133.13 (d, J CP ) 57.4 Hz), 130.99, 130.97, 129.46 (m), 129.17
Hz), 18.96; 31P{1H} NMR (162 MHz, CD2Cl2) δ 30.50 (d, J CP
)
-
22.5 Hz), 11.79 (d, J CP ) 22.3 Hz). Anal. Calcd for C39H33
(44) Keegstra, M. A.; Klomp, A. J . A.; Brandsma, L. Synth. Commun.
1990, 20, 3371.
(45) Bocchi, V.; Palla, G. Synlett 1982, 1096.
BrFeSP2Pd‚CD2Cl2: C, 51.95; H, 3.57. Found: C, 51.58; H,
3.69.